Clinical Trial

HER2 Vaccine for Locally Advanced Breast Cancer

Name: HER2 Vaccine for Locally Advanced Breast Cancer — clinical trial record (NCT06949410)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

The goal of this study is to test an investigational vaccine to activate the immune system to fight breast cancer.

Protocol Amendment History 3 amendments

This ClinicalTrials.gov record has been amended 3 times since 2025-04-22; most recent amendment 2026-04-21.

Status change: Not Yet Recruiting → Recruiting 2025-08-19

Trial Details

NCT Number	NCT06949410
Lead Sponsor	Pravin T.P Kaumaya
Conditions	Breast Cancer, HER2-positive Breast Cancer
Enrollment	36 participants
Start Date	2026-06
Primary Completion	2029-12 (estimated)
Study Completion	2030-03 (estimated)
Updated on ClinicalTrials.gov	2026-04-22